Cargando…
Natural plant products in treatment of pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH) is a severe disease characterized by progressive remodeling of distal pulmonary arteries and persistent elevation of pulmonary vascular resistance (PVR), which leads to right ventricular dysfunction, heart failure, and eventually death. Although treatment respon...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055327/ https://www.ncbi.nlm.nih.gov/pubmed/29869936 http://dx.doi.org/10.1177/2045894018784033 |
_version_ | 1783341149525639168 |
---|---|
author | Xiang, Lili Li, Ying Deng, Xu Kosanovic, Djuro Schermuly, Ralph Theo Li, Xiaohui |
author_facet | Xiang, Lili Li, Ying Deng, Xu Kosanovic, Djuro Schermuly, Ralph Theo Li, Xiaohui |
author_sort | Xiang, Lili |
collection | PubMed |
description | Pulmonary arterial hypertension (PAH) is a severe disease characterized by progressive remodeling of distal pulmonary arteries and persistent elevation of pulmonary vascular resistance (PVR), which leads to right ventricular dysfunction, heart failure, and eventually death. Although treatment responsiveness for this disease is improving, it continues to be a life-threatening condition. With the clinical efficacy of natural plant products being fully confirmed by years of practice, more and more recognition and attention have been obtained from the international pharmaceutical industry. Moreover, studies over the past decades have demonstrated that drugs derived from natural plants show unique advantages and broad application prospects in PAH treatment, not to mention the historical application of Chinese traditional medicine in cardiopulmonary diseases. In this review, we focus on summarizing natural plant compounds with therapeutic properties in PAH, according to the extracts, fractions, and pure compounds from plants into categories, hoping it to be helpful for basic research and clinical application. |
format | Online Article Text |
id | pubmed-6055327 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-60553272018-07-25 Natural plant products in treatment of pulmonary arterial hypertension Xiang, Lili Li, Ying Deng, Xu Kosanovic, Djuro Schermuly, Ralph Theo Li, Xiaohui Pulm Circ Review Article Pulmonary arterial hypertension (PAH) is a severe disease characterized by progressive remodeling of distal pulmonary arteries and persistent elevation of pulmonary vascular resistance (PVR), which leads to right ventricular dysfunction, heart failure, and eventually death. Although treatment responsiveness for this disease is improving, it continues to be a life-threatening condition. With the clinical efficacy of natural plant products being fully confirmed by years of practice, more and more recognition and attention have been obtained from the international pharmaceutical industry. Moreover, studies over the past decades have demonstrated that drugs derived from natural plants show unique advantages and broad application prospects in PAH treatment, not to mention the historical application of Chinese traditional medicine in cardiopulmonary diseases. In this review, we focus on summarizing natural plant compounds with therapeutic properties in PAH, according to the extracts, fractions, and pure compounds from plants into categories, hoping it to be helpful for basic research and clinical application. SAGE Publications 2018-06-05 /pmc/articles/PMC6055327/ /pubmed/29869936 http://dx.doi.org/10.1177/2045894018784033 Text en © The Author(s) 2018 http://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Review Article Xiang, Lili Li, Ying Deng, Xu Kosanovic, Djuro Schermuly, Ralph Theo Li, Xiaohui Natural plant products in treatment of pulmonary arterial hypertension |
title | Natural plant products in treatment of pulmonary arterial
hypertension |
title_full | Natural plant products in treatment of pulmonary arterial
hypertension |
title_fullStr | Natural plant products in treatment of pulmonary arterial
hypertension |
title_full_unstemmed | Natural plant products in treatment of pulmonary arterial
hypertension |
title_short | Natural plant products in treatment of pulmonary arterial
hypertension |
title_sort | natural plant products in treatment of pulmonary arterial
hypertension |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055327/ https://www.ncbi.nlm.nih.gov/pubmed/29869936 http://dx.doi.org/10.1177/2045894018784033 |
work_keys_str_mv | AT xianglili naturalplantproductsintreatmentofpulmonaryarterialhypertension AT liying naturalplantproductsintreatmentofpulmonaryarterialhypertension AT dengxu naturalplantproductsintreatmentofpulmonaryarterialhypertension AT kosanovicdjuro naturalplantproductsintreatmentofpulmonaryarterialhypertension AT schermulyralphtheo naturalplantproductsintreatmentofpulmonaryarterialhypertension AT lixiaohui naturalplantproductsintreatmentofpulmonaryarterialhypertension |